Vicryl Plus and Monocryl Plus in Breast Surgery
Not Applicable
Completed
- Conditions
- Breast Cancer Surgery
- Registration Number
- NCT00830271
- Lead Sponsor
- Cardiff and Vale University Health Board
- Brief Summary
This is a randomised pilot study comparing conventional sutures (Vicryl and Monocryl) with antiseptic coated equivalents (Vicryl plus andf Monocryl plus) in elective breast surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 150
Inclusion Criteria
- All patients over 18 years old who attend the Cardiff and Vale NHS Trust for elective breast cancer surgery
Exclusion Criteria
- patients unable to give consent or comply with follow up
- patients undergoing surgery for benign disease
- patients with inflammatory cancers or skin ulceration
- patients having neo-adjuvant chemotherapy or radiotherapy
- patients with known allergy to triclosan antiseptic
- patients with immune deficiency diseases
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method reduction of surgical site infection 6-7 months
- Secondary Outcome Measures
Name Time Method estimation time in hospital and return to work numbers of haematomas and seromas 6-9 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the antimicrobial efficacy of antiseptic-coated sutures in breast surgery?
How do Vicryl Plus and Monocryl Plus compare to conventional sutures in reducing surgical site infections post-breast cancer surgery?
Are there specific biomarkers that predict better outcomes with antiseptic-coated sutures in elective breast procedures?
What are the potential adverse events associated with antiseptic-coated sutures in breast surgery and how are they managed?
What are the current trends in antimicrobial suture development for breast cancer surgery, including competitor products and combination approaches?
Trial Locations
- Locations (1)
Cardiff and Vale NHS Trust
🇬🇧Cardiff, Wales, United Kingdom
Cardiff and Vale NHS Trust🇬🇧Cardiff, Wales, United Kingdom